PLP1 and myeloid sarcoma: Interestingly, PLP1 mutations have also been linked to multiple sclerosis (MS), where they appear to facilitate pathogenic immune responses and lymphocyte activation, suggesting that genetic and inflammatory mechanisms may converge on common oligodendroglial targets [94].